Chow K, Sommerlad W, Boehrer S, Schneider B, Seipelt G, Rummel M, Hoelzer D, Mitrou P, Weidmann E. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases. Haematologica 2002; 87(1):33-43.